Podium Presentations
Cell and gene therapy formulation technologies: transitioning clinical therapies to medicines
Nia Stevens | Investigator, Formulation and delivery, GSK, UK
Creative formulation approaches to overcome new and old challenges
Bernardo Perez-Ramirez | Senior Scientific Director, Genzyme (Sanofi Company), USA
Combining computational approaches and experiments for selecting compounds with the desired properties, applied in particular to the osmolyte-like effects on the thermal stability of a monoclonal antibody
Andreas Bender | Lecturer for molecular informatics and drug design, University of Cambridge, UK
